Patent details

EP3752190 Title: ANTI-CANCER REGIMEN USING ANTI-CD47 AND ANTI-CD20 ANTIBODIES

Basic Information

Publication number:
EP3752190
PCT Application Number:
US2019017466
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP197098189
PCT Publication Number:
WO2019157432
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-CANCER REGIMEN USING ANTI-CD47 AND ANTI-CD20 ANTIBODIES
French Title of Invention:
REGIME CONTRE LE CANCER UTILISANT DES ANTICORPS ANTI-CD47 ET ANTI-CD20
German Title of Invention:
ANTI-KREBS BEHANDLUM MIT ANTI-CD47- UND ANTI-CD20-ANTIKÖRPERN
SPC Number:

Dates

Filing date:
11/02/2019
Grant date:
06/07/2022
EP Publication Date:
23/12/2020
PCT Publication Date:
15/08/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/07/2022
EP B1 Publication Date:
06/07/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/02/2023
Expiration date:
11/02/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/06/2022
 
 

Name:
Forty Seven, Inc.
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

Inventor

1

Name:
CHAO, Mark Ping
Address:
United States (US)

2

Name:
VOLKMER, Jens-Peter
Address:
United States (US)

3

Name:
TAKIMOTO, Chris Hidemi Mizufune
Address:
United States (US)

Priority

1

Priority Number:
201862629340 P
Priority Date:
12/02/2018
Priority Country:
United States (US)

2

Priority Number:
201862678468 P
Priority Date:
31/05/2018
Priority Country:
United States (US)

3

Priority Number:
201862743060 P
Priority Date:
09/10/2018
Priority Country:
United States (US)

4

Priority Number:
201862743875 P
Priority Date:
10/10/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; C07K 16/28; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202227
Publication date:
06/07/2022
Description:
Grant (B1)

2

Issue number:
202232
Publication date:
10/08/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages